Confirmed Control Closed Transaction verified Cold RemediesConsumerConsumer Healthcare / OTC Cold RemediesNasal Cold RemedyOTC Healthcare
Zicam acquired by Church & Dwight
Church & Dwight acquired Zicam, an US consumer healthcare / otc cold remedies brand on Dec 1, 2020. The transaction value is shown as USD 530m. The current comp implies EV / revenue of 5.9x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Zicam
- Acquirer
- Church & Dwight
- Seller
- -
- Announced
- 2020-12-01
- Geography
- United States
- Tags
- Cold RemediesConsumerConsumer Healthcare / OTC Cold RemediesNasal Cold RemedyOTC Healthcare
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
USD 530M
Consideration | USD
Basis: Public source
EV / revenue
5.9x
Period not stated
Basis: FundComb estimate
EV / EBITDA
14.7x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- USD 530m consideration is treated as publicly disclosed or derived directly from public source data.
- EV / revenue is shown as 5.9x based on the available comp inputs.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- EV / EBITDA is shown as 14.7x based on the available comp inputs.
Source summary
No public source summary has been published for this transaction yet.